CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 444508-444841 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T26074","span":{"begin":0,"end":229},"obj":"Sentence"},{"id":"T58220","span":{"begin":230,"end":333},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The course of RR-MS appears to be largely driven by the inflammatory process; conversely neurodegeneration, which at least in part develops independent from inflammation, drives chronic brain injury in patients with PP and SP-MS. Antiinflammatory therapies and immune modulation have shown a beneficial effect only in RR-MS patients."}

{"project":"Epistemic_Statements","denotations":[{"id":"T970","span":{"begin":0,"end":333},"obj":"Epistemic_statement"}],"text":"The course of RR-MS appears to be largely driven by the inflammatory process; conversely neurodegeneration, which at least in part develops independent from inflammation, drives chronic brain injury in patients with PP and SP-MS. Antiinflammatory therapies and immune modulation have shown a beneficial effect only in RR-MS patients."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T301","span":{"begin":0,"end":229},"obj":"Sentence"},{"id":"T302","span":{"begin":230,"end":333},"obj":"Sentence"}],"text":"The course of RR-MS appears to be largely driven by the inflammatory process; conversely neurodegeneration, which at least in part develops independent from inflammation, drives chronic brain injury in patients with PP and SP-MS. Antiinflammatory therapies and immune modulation have shown a beneficial effect only in RR-MS patients."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T949","span":{"begin":89,"end":106},"obj":"Phenotype"}],"attributes":[{"id":"A949","pred":"hp_id","subj":"T949","obj":"http://purl.obolibrary.org/obo/HP_0002180"}],"text":"The course of RR-MS appears to be largely driven by the inflammatory process; conversely neurodegeneration, which at least in part develops independent from inflammation, drives chronic brain injury in patients with PP and SP-MS. Antiinflammatory therapies and immune modulation have shown a beneficial effect only in RR-MS patients."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1973","span":{"begin":17,"end":19},"obj":"Body_part"},{"id":"T1974","span":{"begin":186,"end":191},"obj":"Body_part"},{"id":"T1975","span":{"begin":226,"end":228},"obj":"Body_part"},{"id":"T1976","span":{"begin":321,"end":323},"obj":"Body_part"}],"attributes":[{"id":"A1973","pred":"uberon_id","subj":"T1973","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A1974","pred":"uberon_id","subj":"T1974","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A1975","pred":"uberon_id","subj":"T1975","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A1976","pred":"uberon_id","subj":"T1976","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"The course of RR-MS appears to be largely driven by the inflammatory process; conversely neurodegeneration, which at least in part develops independent from inflammation, drives chronic brain injury in patients with PP and SP-MS. Antiinflammatory therapies and immune modulation have shown a beneficial effect only in RR-MS patients."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2801","span":{"begin":14,"end":19},"obj":"Disease"},{"id":"T2802","span":{"begin":17,"end":19},"obj":"Disease"},{"id":"T2803","span":{"begin":157,"end":169},"obj":"Disease"},{"id":"T2804","span":{"begin":186,"end":198},"obj":"Disease"},{"id":"T2805","span":{"begin":192,"end":198},"obj":"Disease"},{"id":"T86795","span":{"begin":223,"end":228},"obj":"Disease"},{"id":"T2807","span":{"begin":226,"end":228},"obj":"Disease"},{"id":"T2808","span":{"begin":318,"end":323},"obj":"Disease"},{"id":"T2809","span":{"begin":321,"end":323},"obj":"Disease"},{"id":"T2779","span":{"begin":14,"end":19},"obj":"Disease"},{"id":"T69733","span":{"begin":17,"end":19},"obj":"Disease"},{"id":"T53584","span":{"begin":157,"end":169},"obj":"Disease"},{"id":"T22646","span":{"begin":186,"end":198},"obj":"Disease"},{"id":"T97781","span":{"begin":192,"end":198},"obj":"Disease"},{"id":"T37740","span":{"begin":223,"end":228},"obj":"Disease"},{"id":"T30757","span":{"begin":226,"end":228},"obj":"Disease"},{"id":"T8226","span":{"begin":318,"end":323},"obj":"Disease"},{"id":"T53381","span":{"begin":321,"end":323},"obj":"Disease"}],"attributes":[{"id":"A2801","pred":"mondo_id","subj":"T2801","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A2802","pred":"mondo_id","subj":"T2802","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A2803","pred":"mondo_id","subj":"T2803","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A2804","pred":"mondo_id","subj":"T2804","obj":"http://purl.obolibrary.org/obo/MONDO_0043510"},{"id":"A2805","pred":"mondo_id","subj":"T2805","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A2806","pred":"mondo_id","subj":"T86795","obj":"http://purl.obolibrary.org/obo/MONDO_0000450"},{"id":"A2807","pred":"mondo_id","subj":"T2807","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A2808","pred":"mondo_id","subj":"T2808","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A2809","pred":"mondo_id","subj":"T2809","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A94866","pred":"mondo_id","subj":"T2779","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A37732","pred":"mondo_id","subj":"T69733","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A37597","pred":"mondo_id","subj":"T53584","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A48696","pred":"mondo_id","subj":"T22646","obj":"http://purl.obolibrary.org/obo/MONDO_0043510"},{"id":"A40625","pred":"mondo_id","subj":"T97781","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A70349","pred":"mondo_id","subj":"T37740","obj":"http://purl.obolibrary.org/obo/MONDO_0000450"},{"id":"A42121","pred":"mondo_id","subj":"T30757","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A50764","pred":"mondo_id","subj":"T8226","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A97682","pred":"mondo_id","subj":"T53381","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"The course of RR-MS appears to be largely driven by the inflammatory process; conversely neurodegeneration, which at least in part develops independent from inflammation, drives chronic brain injury in patients with PP and SP-MS. Antiinflammatory therapies and immune modulation have shown a beneficial effect only in RR-MS patients."}